Lv61
2950 积分 2021-08-10 加入
Preclinical Characterization and Clinical Activity of RNK08954, a Highly Selective and Orally Bioavailable KRAS G12D Inhibitor
1个月前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
3个月前
已完结
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
3个月前
已完结
New limits proposed for the management of non-mutagenic impurities
3个月前
已完结
TIGIT regulates CD4+ T cell immunity against polymicrobial sepsis
4个月前
已完结
Kras G12C– and G12D–driven lung cancers differ in oncogenic potency, immunogenicity, and relapse after Kras inhibition in mouse models
4个月前
已完结
LBA84 Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D-mutant pancreatic ductal adenocarcinoma (PDAC)
7个月前
已关闭
2215O HRS-4642 combined with gemcitabine and nab-paclitaxel in KRAS-G12D mutant advanced pancreatic cancer: A phase Ib/II study
7个月前
已关闭
Trends in gene therapy delivery technologies
7个月前
已完结
皖公网安备34019202002308
